Literature DB >> 22011044

Overexpression of S100B, TM4SF4, and OLFM4 genes is correlated with liver metastasis in Taiwanese colorectal cancer patients.

Ming-Yii Huang1, Hwei-Ming Wang, Hui-Jen Chang, Chao-Peng Hsiao, Jaw-Yuan Wang, Shiu-Ru Lin.   

Abstract

Distant metastasis of colorectal cancer (CRC) occurs mainly in the liver and is the major cause of death. This study explored the overexpression of liver metastasis-associated mRNAs in human CRC by using a well-established, weighted enzymatic chip array platform. Analysis of 10 CRC tissue specimens compared with their normal adjacent tissues revealed that ATP2A2, ELAVL4, hTERT, KCTD2, MUC1, OLFM4, S100B, and TM4SF4 genes were upregulated (gene expression ratio of cancer tissue to paired normal tissue was >2) by microarray and bioinformatics analysis. A gene chip including eight candidate genes was constructed to investigate the circulating tumor cells in blood specimens of 103 preoperative CRC patients and further validated by reverse transcriptase-polymerase chain reaction. Liver metastasis was significantly correlated with overexpression of S100B (p=0.001, OR=9.217), TM4SF3 (p=0.011, OR=4.385), and OLFM4 (p=0.015, OR=3.438). These results suggest that S100B, TM4SF3, and OLFM4 overexpression may affect metastatic behavior of tumor cells in Taiwanese CRC patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22011044      PMCID: PMC3246415          DOI: 10.1089/dna.2011.1264

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  26 in total

1.  DAVID: Database for Annotation, Visualization, and Integrated Discovery.

Authors:  Glynn Dennis; Brad T Sherman; Douglas A Hosack; Jun Yang; Wei Gao; H Clifford Lane; Richard A Lempicki
Journal:  Genome Biol       Date:  2003-04-03       Impact factor: 13.583

2.  Molecular detection of breast cancer cells in the peripheral blood of advanced-stage breast cancer patients using multimarker real-time reverse transcription-polymerase chain reaction and a novel porous barrier density gradient centrifugation technology.

Authors:  Megan K Baker; Kaidi Mikhitarian; Walid Osta; Kathi Callahan; Rana Hoda; Frank Brescia; Rayna Kneuper-Hall; Michael Mitas; David J Cole; William E Gillanders
Journal:  Clin Cancer Res       Date:  2003-10-15       Impact factor: 12.531

3.  Increased detection of circulating tumor cells in the blood of colorectal carcinoma patients using two reverse transcription-PCR assays and multiple blood samples.

Authors:  R Q Wharton; S K Jonas; C Glover; Z A Khan; A Klokouzas; H Quinn; M Henry; T G Allen-Mersh
Journal:  Clin Cancer Res       Date:  1999-12       Impact factor: 12.531

4.  Clearance of circulating tumor cells after excision of primary colorectal cancer.

Authors:  Hitesh Patel; Nadia Le Marer; Richard Q Wharton; Zulfiqar A J Khan; Ruth Araia; Clare Glover; Michael M Henry; Timothy G Allen-Mersh
Journal:  Ann Surg       Date:  2002-02       Impact factor: 12.969

5.  S100B protein expressions as an independent predictor of early relapse in UICC stages II and III colon cancer patients after curative resection.

Authors:  Chi-Ching Hwang; Han-Tan Chai; Hsin-Wei Chen; Hsiang-Lin Tsai; Chien-Yu Lu; Fang-Jung Yu; Ming-Yii Huang; Jaw-Yuan Wang
Journal:  Ann Surg Oncol       Date:  2010-07-14       Impact factor: 5.344

Review 6.  Molecular detection and characterisation of circulating tumour cells and micrometastases in solid tumours.

Authors:  R A Ghossein; S Bhattacharya
Journal:  Eur J Cancer       Date:  2000-08       Impact factor: 9.162

7.  Dissemination of tumor cells in patients undergoing surgery for colorectal cancer.

Authors:  J Weitz; P Kienle; J Lacroix; F Willeke; A Benner; T Lehnert; C Herfarth; M von Knebel Doeberitz
Journal:  Clin Cancer Res       Date:  1998-02       Impact factor: 12.531

8.  Detection and characterization of carcinoma cells in the blood.

Authors:  E Racila; D Euhus; A J Weiss; C Rao; J McConnell; L W Terstappen; J W Uhr
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

9.  Value of postoperative surveillance after radical surgery for colorectal cancer: results of a cohort study.

Authors:  A Castells; X Bessa; M Daniels; C Ascaso; A M Lacy; J C García-Valdecasas; L Gargallo; F Novell; E Astudillo; X Filella; J M Piqué
Journal:  Dis Colon Rectum       Date:  1998-06       Impact factor: 4.585

10.  Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay.

Authors:  D S Hoon; Y Wang; P S Dale; A J Conrad; P Schmid; D Garrison; C Kuo; L J Foshag; A J Nizze; D L Morton
Journal:  J Clin Oncol       Date:  1995-08       Impact factor: 44.544

View more
  21 in total

Review 1.  Functional analysis of Cullin 3 E3 ligases in tumorigenesis.

Authors:  Ji Cheng; Jianping Guo; Zhiwei Wang; Brian J North; Kaixiong Tao; Xiangpeng Dai; Wenyi Wei
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2017-11-08       Impact factor: 10.680

2.  Role of TM4SF1 in regulating breast cancer cell migration and apoptosis through PI3K/AKT/mTOR pathway.

Authors:  Yonghong Sun; Yahong Xu; Jie Xu; Dan Lu; Jianyu Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

3.  MicroRNA-30a-5p (miR-30a) regulates cell motility and EMT by directly targeting oncogenic TM4SF1 in colorectal cancer.

Authors:  Y R Park; S L Kim; M R Lee; S Y Seo; J H Lee; S H Kim; I H Kim; S O Lee; S T Lee; Sang Wook Kim
Journal:  J Cancer Res Clin Oncol       Date:  2017-05-20       Impact factor: 4.553

Review 4.  Novel antigens for targeted radioimmunotherapy in hepatocellular carcinoma.

Authors:  Mahsa Pourhamzeh; Samieh Asadian; Hamed Mirzaei; Azita Minaei; Elahe Shahriari; Anastasia Shpichka; Hamidreza Aboulkheyr Es; Peter Timashev; Moustapha Hassan; Massoud Vosough
Journal:  Mol Cell Biochem       Date:  2022-06-16       Impact factor: 3.396

Review 5.  S100 protein family in human cancer.

Authors:  Hongyan Chen; Chengshan Xu; Qing'e Jin; Zhihua Liu
Journal:  Am J Cancer Res       Date:  2014-03-01       Impact factor: 6.166

6.  Plasma olfactomedin 4 level in peripheral blood and its association with clinical features of breast cancer.

Authors:  Chaoqian Liu; Yan Guo; Weiwei Wu; Zhenzhen Zhang; Lu Xu; Kainan Wu; Wei Hu; Guoping Liu; Junyi Shi; Cheng Xu; Jianwei Bi; Yuan Sheng
Journal:  Oncol Lett       Date:  2017-10-16       Impact factor: 2.967

Review 7.  Emerging Mechanisms and Treatment Progress on Liver Metastasis of Colorectal Cancer.

Authors:  Wubin Zheng; Fan Wu; Kai Fu; Guangshun Sun; Guoqiang Sun; Xiao Li; Wei Jiang; Hongyong Cao; Hanjin Wang; Weiwei Tang
Journal:  Onco Targets Ther       Date:  2021-05-06       Impact factor: 4.147

Review 8.  The emerging role of the KCTD proteins in cancer.

Authors:  Annapaola Angrisani; Annamaria Di Fiore; Enrico De Smaele; Marta Moretti
Journal:  Cell Commun Signal       Date:  2021-05-17       Impact factor: 5.712

9.  S100 proteins as diagnostic and prognostic markers in colorectal and hepatocellular carcinoma.

Authors:  Claudia Maletzki; Peggy Bodammer; Anne Breitrück; Claus Kerkhoff
Journal:  Hepat Mon       Date:  2012-10-12       Impact factor: 0.660

10.  Methanolic extracts of bitter melon inhibit colon cancer stem cells by affecting energy homeostasis and autophagy.

Authors:  Deep Kwatra; Dharmalingam Subramaniam; Prabhu Ramamoorthy; David Standing; Elizabeth Moran; Ravichandiran Velayutham; Ashim Mitra; Shahid Umar; Shrikant Anant
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-06       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.